Publications

Recent Articles and Reviews 2019

  • D’Amico L, Menzel U, Prummer M, Müller P, Buchi M, Kashyap A, Haessler U, Yermanos A, Gébleux R, Briendl M, Hell T, Wolter F, Beerli R, Truxova I, Špíšek R, Vlajnic T, Grawunder U, Reddy S, Zippelius A. A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer.
    DOI: 10.1186/s40425-018-0464-1

Recent Articles and Reviews 2018

  • Pearce OMT, Läubli H. Cancer Immunotherapy. Glycobiology, (2018), doi: 10.1093/glycob/cwy069
    DOI: 10.1093/glycob/cwy069
  • Ortega Sanchez G, Jahn K, Savic S, Zippelius A, Läubli H. Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab. J Immunother Cancer, (2018), doi: 10.1186/s40425-018-0400-4
    DOI: 10.1186/s40425-018-0400-4
  • Läubli H, Dirnhofer S, Zippelius A. Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapy. Virchows Arch, (2018), doi: 10.1007/s00428-018-2435-9
    DOI :10.1007/s00428-018-2435-9
  • Stanczak MA, Siddiqui SS, Trefny MP, Thommen DS, Boligan KF, von Gunten S, Tzankov A, Tietze L, Lardinois D, Heinzelmann-Schwarz V, von Bergwelt-Baildon MS, Zhang W, Lenz HJ, Han Y, Amos CI, Syedbasha M, Egli A, Stenner F, Speiser DE, Varki A, Zippelius A, Läubli H. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. J Clin Invest, (2018), doi: 10.1172/JCI120612
    DOI: 10.1172/JCI120612
  • Heinz Läubli, Catharina Balmelli, Lukas Kaufmann, Michal Stanczak, Mohammedyaseen Syedbasha, Dominik Vogt, Astrid Hertig, Beat Müller, Oliver Gautschi, Frank Stenner, Alfred Zippelius, Adrian Egli and Sacha I. Rothschild. Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events. Journal for ImmunoTherapy of Cancer, (2018), doi.org/10.1186/s40425-018-0353-7
    https://doi.org/10.1186/s40425-018-0353-7
  • Daniela S. Thommen, Viktor H. Koelzer Petra Herzig, Andreas Roller, Marcel Trefny, Sarah Dimeloe, Anna Kiialainen, Jonathan Hanhart, Catherine Schill, Christoph Hess, Spasenija Savic Prince, Mark Wiese, Didier Lardinois, Ping-Chih Ho, Christian Klein, Vaios Karanikas, Kirsten D. Mertz, Ton N. Schumacher and Alfred Zippelius. A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nature Medicine, (2018), doi: 10.1038/s41591-018-0057-z
    https://doi.org/10.1038/s41591-018-0057-z
  • Berline Murekatete, Ali Shokoohmand, Jacqui McGovern, Lipsa Mohanty, Christoph Meinert, Brett G. Hollier, Alfred Zippelius, Zee Upton & Abhishek S. Kashyap. Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma Progression. Scientific Reports, (2018) 8:583 | DOI:10.1038/s41598-017-19073-4
  • Heinz Läubli, Philipp Müller, Lucia D’Amico, Mélanie Buchi, Abhishek S. Kashyap, Alfred Zippelius. The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models. Cancer Immunology, (2018) doi.org/10.1007/s00262-018-2136-x https://link.springer.com/article/10.1007%2Fs00262-018-2136-x

Recent Articles and Reviews 2017

Recent Articles and Reviews (2016)

Articles and Reviews 2015

Articles and Reviews 2014